(Q44490443)

3 December 2017

title

Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism (English)

1 reference

3 December 2017

0 references

7

1 reference

3 December 2017

2

Maria A Oquendo

1 reference

3 December 2017

1

Leo Sher

1 reference

3 December 2017

5

Michael F Grunebaum

1 reference

3 December 2017

6

Ainsley K Burke

1 reference

3 December 2017

Shuhua Li

3

1 reference

3 December 2017

Yung-yu Huang

series ordinal

4

1 reference

3 December 2017

J John Mann

series ordinal

8

1 reference

3 December 2017

language of work or name

English

0 references

publication date

25 June 2003

1 reference

3 December 2017

published in

Neuropsychopharmacology

1 reference

3 December 2017

volume

28

1 reference

3 December 2017

issue

9

1 reference

3 December 2017

page(s)

1712-1719

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300231

3 December 2017

exact match

0 references

cites work

Inverse relationship between CSF TRH concentrations and the TSH response to TRH in abstinent alcohol-dependent patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Alcohol, aggression and serotonin: metabolic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

FACTOR ANALYSIS OF SOME PSYCHOMETRIC MEASURES OF IMPULSIVENESS AND ANXIETY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Assessment of suicidal intention: The Scale for Suicide Ideation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Cross-validation of the Suicidal Intent Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of cerebrospinal fluid acid monoamine metabolite measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Human aggression and suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Age of alcoholism onset. I. Relationship to psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Childhood personality predicts alcohol abuse in young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Patterns of suicidality and alcohol use in alcoholics with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindoleacetic acid levels than late-onset alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Concentrations of corticotropin-releasing hormone, norepinephrine, MHPG, 5-hydroxyindoleacetic acid, and tryptophan in the cerebrospinal fluid of alcoholic patients: serial sampling studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Cholecystokinin in human cerebrospinal fluid: concentrations, dynamics, molecular forms and relationship to fasting and feeding in health, depression and alcoholism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

A longitudinal study of the order of onset of alcohol dependence and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

D2 dopamine receptor genotype and cerebrospinal fluid homovanillic acid, 5-hydroxyindoleacetic acid and 3-methoxy-4-hydroxyphenylglycol in alcoholics in Finland and the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Additional psychiatric illness by Diagnostic Interview Schedule in male alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Psychopathology in hospitalized alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Cerebrospinal fluid HVA, central brain atrophy, and clinical state in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Cerebrospinal fluid homovanillic acid levels are not reduced in early corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Role of the dopaminergic system in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Changes in the Metabolism of Biogenic Amines in Alcoholism—Especially Regarding CSF Monoamine Metabolites and Serum DBH Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Neural mechanisms of drug reinforcement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Low HVA and normal 5HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: correlations to symptomatology and family history

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Current concepts in the treatment of depression in alcohol-dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Effect of haloperidol on measures of craving and impaired control in alcoholic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Alcoholism and the dopaminergic system: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

The biology of impulsivity and suicidality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Serotonin and aggression and the alcohol-aggression relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Psychomotor Activity and Cerebrospinal Fluid Amine Metabolites in Affective Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Ethanol drinking following 6-OHDA lesions of nucleus accumbens and tuberculum olfactorium of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

CSF amine metabolites in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

High correlation between salivary MHPG and CSF MHPG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

The neural basis of drug craving: an incentive-sensitization theory of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Mental disorders among alcoholics. Relationship to age of onset and cerebrospinal fluid neuropeptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Oral ethanol self-administration: a behavioral pharmacological approach to CNS control mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Genetic and clinical implications of alcoholism and affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Lumbar cerebrospinal fluid homovanillic acid concentrations are higher in female than male non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

CSF and plasma MHPG, and CSF MHPG index: pretreatment levels in diagnostic groups and response to somatic treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

CSF studies in violent offenders. I. 5-HIAA as a negative and HVA as a positive predictor of psychopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Correlations between aminergic metabolites simultaneously obtained from human CSF and brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

A prospective follow-up study of alcoholic violent offenders and fire setters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Craving for alcohol and dopamine receptor sensitivity in alcohol-dependent men and control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Correlation of clinical symptoms, HVA and 5-HIAA in CSF and plasma L-DOPA in parkinsonian patients treated with L-DOPA and L-DOPA + RO 4-4602

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

Higher CSF levels of HVA and 5-HIAA in delusional compared to nondelusional depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Levels of gamma-aminobutyric acid in cerebrospinal fluid and plasma during alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

5-HIAA and HVA in CSF in patients with idiopathic pain disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

CSF monoamine metabolites in melancholia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

The measurement of pessimism: the hopelessness scale.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Research: Methods, Mechanisms, and Causes Introduction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Endorphin levels in human cerebrospinal fluid during alcohol intoxication and withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Dopamine and depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Personality differences predict health-risk behaviors in young adulthood: evidence from a longitudinal study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

CSF monoamine metabolites in relation to the diagnostic interview for borderline patients (DIB)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Disproportionate suicidality in patients with comorbid major depression and alcoholism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Relapse in violent crime in relation to cerebrospinal fluid monoamine metabolites (5-HIAA, HVA and HMPG) in male forensic psychiatric patients convicted of murder: a 16-year follow-up

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Co-morbid depression and drinking outcome in those with alcohol dependence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

MMPI measures of impulsivity and depression correlate with CSF 5-HIAA and HVA in depression but not schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Cerebrospinal fluid neuroendocrinology of alcohol misusers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Low CSF concentration of a dopamine metabolite in tobacco smokers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Prevalence and correlates of alcohol use and DSM-IV alcohol dependence in the United States: results of the National Longitudinal Alcohol Epidemiologic Survey.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Elevated cerebrospinal fluid histidine in alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

CSF 5-HIAA and HVA concentrations in elderly depressed patients who attempted suicide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Plasma and CSF HVA levels in panic patients with comorbid social phobia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Biogenic amine metabolites in the CSF of patients with late onset and alcoholic ataxias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Personality and Cerebrospinal Fluid Monoamine Metabolites in Alcoholics and Controls

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Biogenic amine metabolites in delusional (psychotic) depression and melancholia subtypes of major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Gradients of CSF monoamine metabolites: a comparison between male and female volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

A follow-up study on alcoholics with and without co-existing affective disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Depression among alcoholics. Relationship to clinical and cerebrospinal fluid variables

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Cerebrospinal fluid monoamine metabolites in alcoholic patients who attempt suicide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

CSF studies on alcoholism and related behaviours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Alcoholism and depression in a Swedish female population: co-morbidity and risk factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Hypnotizability and CSF HVA levels among psychiatric patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

CSF monoamine metabolites in patients and controls: support for a bimodal distribution in major affective disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Etiology of alcoholism reconsidered. The case for a biopsychosocial process

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300231

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300231

1 reference

Dimensions Publication ID

3 December 2017

1015068056

0 references

1 reference